| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $22.18B | $22.94B | $23.02B | $20.30B | $15.29B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $411.00M | $426.00M | $408.00M | $345.00M | $321.00M |
| SG&A | $239.00M | $239.00M | $226.00M | $240.00M | $204.00M |
| Operating Income | $2.26B | $3.82B | $4.08B | $2.71B | $1.80B |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $479.00M | $718.00M | $701.00M | $515.00M | -$216.00M |
| Net Income | $1.28B | $2.50B | $2.64B | $1.57B | $1.46B |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $853.00M | $883.00M | $902.00M | $908.00M | $892.00M |